advertisement
Clinical Ophthalmology 86
Showing records 1 to 25 | Display all abstracts in Clinical Ophthalmology61754 Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
Inoue K
Clinical Ophthalmology 2015; 9: 619-623
61692 Virtual glaucoma clinics: patient acceptance and quality of patient education compared to standard clinics
Court JH
Clinical Ophthalmology 2015; 9: 745-749
61084 Selective laser trabeculoplasty: current perspectives
Leahy KE
Clinical Ophthalmology 2015; 9: 833-841
61032 Aqueous misdirection following pars plana vitrectomy and silicone oil injection
Ghoraba HH
Clinical Ophthalmology 2015; 9: 903-906
61033 Epidemiology of uveitis in the mid-Atlantic United States
Bajwa A
Clinical Ophthalmology 2015; 9: 889-901
61752 Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure
Quaranta L
Clinical Ophthalmology 2015; 9: 633-643
61753 Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
Cvenkel B
Clinical Ophthalmology 2015; 9: 625-631
61510 Micropulse diode laser trabeculoplasty in Nigerian patients
Babalola OE
Clinical Ophthalmology 2015; 9: 1347-1351
61107 Tube shunt coverage with gamma-irradiated cornea allograft (VisionGraft)
Ekici F
Clinical Ophthalmology 2015; 9: 751-755
61368 Ocular neovascularization in eyes with a central retinal artery occlusion or a branch retinal artery occlusion
Mason JO
Clinical Ophthalmology 2015; 9: 995-1000
61286 Plateau iris in Japanese patients with primary angle closure and primary angle closure glaucoma
Mizoguchi T
Clinical Ophthalmology 2015; 9: 1159-1163
61341 A case of WAGR syndrome in association with developmental glaucoma requiring bilateral Baerveldt glaucoma implants and subsequent tube repositioning
Akagi T
Clinical Ophthalmology 2015; 9: 1081-1084
61099 Patient satisfaction with glaucoma therapy: reality or myth?
Lemij HG
Clinical Ophthalmology 2015; 9: 785-793
61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Lam WC
Clinical Ophthalmology 2015; 9: 1255-1268
61544 Prevalence of comorbid retinal disease in patients with glaucoma at an academic medical center
Griffith JF
Clinical Ophthalmology 2015; 9: 1275-1284
61039 Management of exfoliative glaucoma: challenges and solutions
Holló G
Clinical Ophthalmology 2015; 9: 907-919
61733 A review of the iStent(®) trabecular micro-bypass stent: safety and efficacy
Wellik SR
Clinical Ophthalmology 2015; 9: 677-684
61379 Outcomes of Ahmed glaucoma valve implantation in advanced primary congenital glaucoma with previous surgical failure
Huang J
Clinical Ophthalmology 2015; 9: 977-983
61085 Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
Schnober D
Clinical Ophthalmology 2015; 9: 825-832
61481 Noninvasive intraocular pressure monitoring: current insights
de Smedt S
Clinical Ophthalmology 2015; 9: 1385-1392
61086 The eye drop chart: a pilot study for improving administration of and compliance with topical treatments in glaucoma patients
McVeigh KA
Clinical Ophthalmology 2015; 9: 813-819
61508 Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma
Naito T
Clinical Ophthalmology 2015; 9: 1373-1378
61544 Prevalence of comorbid retinal disease in patients with glaucoma at an academic medical center
Goldberg JL
Clinical Ophthalmology 2015; 9: 1275-1284
61754 Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
Shiokawa M
Clinical Ophthalmology 2015; 9: 619-623
61099 Patient satisfaction with glaucoma therapy: reality or myth?
Hoevenaars JG
Clinical Ophthalmology 2015; 9: 785-793